+390677209020 | +39 0267380552 info@direnzo.biz | sedemilano@direnzo.biz

Lingua

Workshop on narcotic and psychotropic substances

The first workshop on narcotic and psychotropic substances (Update on the management of import and export licenses, quarterly and annual...

Wearables and domotics for custom-made therapies

The results of a new sensor device to detect the movements of patients with Parkinson disease revived the interest in custom-made devices and for domotics applied...

The reasons behind our choice

What we built in these 30 years of regulatory activity has now reached maturity. The Art Nouveau building that hosted the headquarters...

Cosmetic importation from extra-EU countries: economic benefit in compliance with the European regulations

It often happens that extra-EU companies, and sometimes even people coming back from China, Philippines, Iran and other, think that...

New headquarters for Di Renzo Regulatory Affairs

wo thousand square meters on four floors, and almost 100 employees. This is the new face of Di Renzo Regulatory...

Regulation on food for special medical purposes

Delegated Regulation (EU) 2016/128 of 15 September 2015 applies as of 22 February, except for the provisions for food for...

Antifraud stickers and traceability of medicines: in Italy still until 2025

Drug serialisation is a tool to improve product safety, ensure patients’ health and prevent frauds. As of February 2019 all...

Pharmaceutical Conferences and congresses

In order to organise conferences, congresses, or meetings opened to health professionals, in Italy or abroad – on topics related...

Brexit’s MHRA guideline for medical devices

The British competent Authority MHRA has published a guideline on their website on the Brexit, that is constantly updated: “Further guidance note on the...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26